147 related articles for article (PubMed ID: 23304903)
1. Prevalence of hepatitis B e antigen in chronic HBV carriers in North-central Nigeria.
Forbi JC; Iperepolu OH; Zungwe T; Agwale SM
J Health Popul Nutr; 2012 Dec; 30(4):377-82. PubMed ID: 23304903
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of hepatitis B virus E antigen among Ghanaian blood donors.
Rufai T; Mutocheluh M; Kwarteng K; Dogbe E
Pan Afr Med J; 2014; 17():53. PubMed ID: 25018803
[TBL] [Abstract][Full Text] [Related]
3. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
Sanders RC; Lewis D; Dyke T; Alpers MP
P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection among sexually active individuals in Nigeria: a cross-sectional study.
Nejo Y; Faneye AO; Olusola B; Bakarey S; Olayinka A; Motayo B;
Pan Afr Med J; 2018; 30():155. PubMed ID: 30455784
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria.
Iroezindu MO; Daniyam CA; Agbaji OO; Isa ES; Okeke EN; Imade GE
J Infect Dev Ctries; 2013 Dec; 7(12):951-9. PubMed ID: 24334942
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Hepatitis B Virus Envelope Antigen and Antibodies Among Chronic Carriers in Ibadan, Nigeria.
Farinloye OI; Otunola A; Fowotade A; Faneye AO
Viral Immunol; 2021 May; 34(4):284-287. PubMed ID: 33999720
[TBL] [Abstract][Full Text] [Related]
7. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
8. Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia.
Shimakawa Y; Lemoine M; Njai HF; Bottomley C; Ndow G; Goldin RD; Jatta A; Jeng-Barry A; Wegmuller R; Moore SE; Baldeh I; Taal M; D'Alessandro U; Whittle H; Njie R; Thursz M; Mendy M
Gut; 2016 Dec; 65(12):2007-2016. PubMed ID: 26185161
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection.
Tseng YR; Wu JF; Ni YH; Chen HL; Chen CC; Wen WH; Hsu HY; Chang MH
Liver Int; 2011 Oct; 31(9):1373-80. PubMed ID: 21745315
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
[TBL] [Abstract][Full Text] [Related]
11. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.
McMahon BJ; Holck P; Bulkow L; Snowball M
Ann Intern Med; 2001 Nov; 135(9):759-68. PubMed ID: 11694101
[TBL] [Abstract][Full Text] [Related]
12. Natural course of persistent hepatitis B virus infection in hepatitis B e antigen-positive and hepatitis B e antigen-negative cohorts in Japan based on the Markov model.
Yamasaki K; Tanaka J; Kurisu A; Akita T; Ohisa M; Sakamune K; Ko K; Sugiyama A; Yasaka T; Shirahama S
J Med Virol; 2018 Dec; 90(12):1800-1813. PubMed ID: 29995323
[TBL] [Abstract][Full Text] [Related]
13. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort.
Zhu L; Zhai X; Wang Q; Jiang J; Peng H; Song C; Ge Z; Qian J; Zhou M; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhu F
J Viral Hepat; 2018 Dec; 25(12):1588-1598. PubMed ID: 30112835
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis B in Nepal: an Asian country with low prevalence of HBV infection.
Shrestha SM; Shrestha S
Trop Gastroenterol; 2012; 33(2):95-101. PubMed ID: 23025054
[TBL] [Abstract][Full Text] [Related]
15. Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection.
Chen CH; Hung CH; Hu TH; Wang JH; Lu SN; Su PF; Lee CM
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1984-92.e1. PubMed ID: 26073492
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
[TBL] [Abstract][Full Text] [Related]
17. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China.
Chen T; Wang J; Qiu H; Yu Q; Yan T; Qi C; Cao F; Tian Z; Guo D; Yao N; Yang Y; He Y; Zhao Y; Liu J
Medicine (Baltimore); 2018 Jul; 97(27):e11406. PubMed ID: 29979437
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, sociodemographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria.
Anaedobe CG; Fowotade A; Omoruyi CE; Bakare RA
Pan Afr Med J; 2015; 20():406. PubMed ID: 26301010
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal.
Shedain PR; Devkota MD; Banjara MR; Ling H; Dhital S
BMC Infect Dis; 2017 Oct; 17(1):667. PubMed ID: 29017456
[TBL] [Abstract][Full Text] [Related]
20. Profile of hepatitis B e antigen-negative chronic hepatitis B.
Amarapurkar DN; Baijal R; Kulshrestha PP; Agal S; Chakraborty MR; Pramanik SS
Indian J Gastroenterol; 2002; 21(3):99-101. PubMed ID: 12118935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
